Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001019687-10-003311)

Filing Details

Accession Number:: 0001019687-10-003311
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2010-09-10 13:19:12
Reporting Period:: 2010-09-08

Filing Date:: 2010-09-10
Accepted Time:: 2010-09-10 13:19:12
Original Submission Date:: 2010-09-09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1355790	International Stem Cell Corp	ISCO.OB	Pharmaceutical Preparations (2834)	204494098

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1478746	R Edmund Wood	C/O International Stem Cell Corp. 2595 Jason Court Oceanside CA 92056	Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-09-08	12,000	$0.39	12,000	No	4	M	Direct
Common Stock	Disposition	2010-09-08	12,000	$1.06	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2010-09-08	12,000	$0.00	12,000	$0.39

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,000		2018-08-25	No	4	M	Direct

Footnotes

The number of shares in Table 1, Box 5 (The Amount of Securities Beneficially Owned Following the Reported Transaction) should have reflected 12,000 shares instead of 13,000 shares as reported in the Form 4 filed on September 9, 2010.
Option issued for 25,000 shares and became exercisable in fifty equal monthly increments of 500 shares commencing 09/25/08.